Deal Makers (& Fakers) Podcast

Niclas Schlopsna

Deal Makers (& Fakers) is my podcast where fundraising gets real. No polished success stories. No fake LinkedIn wins. dealmakersandfakers.substack.com

  1. Jul 17

    The $10B Playbook Most Founders and Fund Managers Learn Too Late

    Capital raising looks like a pitch. It is really a relationship game that starts years before anyone asks for money, and most people learn that the expensive way. Sam Tidswell-Norrish has raised close to $10 billion across private equity funds, and he has sat on every side of the table: As an operator building a firm from scratch, as an investor sourcing deals, and as a founder raising for his own venture. Few people have run the full capital raising loop at his level. On this episode of Deal Makers (& Fakers), Sam joined Niclas Schlopsna, partner at spectup, to walk through what moves money from an investor’s account into yours. Whether you are a founder raising your first round, a fund manager raising your first vehicle, or an investor learning to source better, the same patterns keep showing up. Here is the full breakdown. Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. Capital Raising is a Relationship Game (Not a Pitch Deck one) The single lesson under everything Sam said: money follows trust, and trust is built long before the ask. The founders and managers who close fast are almost never the ones with the best-looking deck. They are the ones who were in the room, useful and consistent, months or years earlier. By the time the raise opens, the investor already knows them, already trusts the work, and the meeting is a formality more than a decision. That reframes the whole exercise. If capital raising is relationship-led, then the real work happens between raises, not during them. It is the quiet, unglamorous months of staying in touch, being helpful with nothing on the table, and letting people watch you deliver. From a Barclays trading floor to raising $10B Sam did not start in private equity. He started on the trading floor at Barclays, where he learned to read markets, price risk, and move quickly under pressure. That grounding shaped how he later approached fundraising, as a numbers-first discipline rather than a charm exercise. The bigger chapter came at Motive Partners, where he was a founding team member and helped build the firm and raise roughly $10 billion. Building a firm from zero taught him the part of capital raising nobody advertises: how hard it is to earn the first believers when you have no track record to point to Your product is performance: Here is the line worth writing down. In private equity, your product is not your fund. Your product is performance. Investors are not buying a legal structure or a slide. They are buying your ability to turn their capital into more capital, repeatedly and predictably. That distinction changes how you present. Instead of talking up the vehicle, you show the machine that produces results: how you source, how you decide, how you improve companies, and why that process holds up across cycles. Founders can borrow the same move. Do not sell the round. Sell the evidence that you can turn money into outcomes. Private equity fundraising vs startup fundraising Sam has done both, so his comparison carries weight. The mechanics differ, but the spine is identical. Startup fundraising sells a future that mostly does not exist yet. You are raising on vision, team, and early signal, and investors price the story. Private equity fundraising sells a repeatable engine backed by a track record, and investors price the proof. One leans on belief, the other on evidence. What carries over both ways: relationships open the door, clarity keeps you in the room, and consistency closes. A founder who understands how LPs scrutinize a fund manager will pitch VCs more sharply, because the underlying question is the same. Can I trust this person with my money, and will I get it back with more. Thanks for reading Deal Makers (& Fakers)! It would mean a lot if you share this post The 7 Ps every investor checks before they wire a dollar Here is the checklist an investor runs before committing. They map closely to what most LPs actually screen for, so use this as the frame and listen to the full episode for his exact phrasing. * People: The team, the track record together, and whether they will stay in the seat. Investors back people first. * Performance: Real, verifiable results. Not projections, not one lucky deal, but a pattern. * Philosophy: A clear, honest view of how you make money and why that edge lasts. * Process: The repeatable system behind the results. Sourcing, diligence, decisions, and value creation. * Portfolio: What you already own or have built, and how it holds up under a hard look. * Price and terms: Fees, structure, and alignment. Investors want to know your incentives point the same way theirs do. * Pipeline: What comes next? A credible line of sight to the deals that will drive the returns you are promising. Miss one, and the smart money hesitates. Nail all seven, and the conversation moves to when, not whether. There are More private equity funds than McDonald’s Sam points to a stat that reframes the whole difficulty of raising today. There are now more private equity funds in the US than there are McDonald’s locations, roughly 19,000 funds against about 14,000 restaurants. Capital is not scarce. Attention and differentiation are. Standing out in that crowd does not come from a louder pitch. It comes from a sharper strategy, a track record you can defend, and relationships that were built before the raise. When thousands of funds all say a version of the same thing, the ones that win are the ones an investor already knows and already trusts. Keeping investor relationships warm: the pen, and one LinkedIn message This is where Sam gets tactical, and where founders can copy him directly. He runs a physical system to keep relationships warm. He writes names on his hand, an old-fashioned pen-on-hand prompt, so he follows up with the people he met before the day’s noise buries them. Low tech, high consistency. Then the story that ties it together. A single, well-judged LinkedIn message to one of the minds behind General Magic, a legendary figure in tech, eventually led to that person joining his board. One message, sent with genuine respect and a clear reason, opened a door most people assume is permanently closed. The lesson is not “spam your dream contacts.” It is that a specific, human, well-timed outreach still works, and most people never send it. Key takeaways * Capital raising is relationship-led. The real work happens between raises, not during them. * In private equity, your product is performance, not your fund. Sell the machine that produces results. * There are more US private equity funds than McDonald’s locations, so differentiation and trust beat volume and noise. * A serious raise takes around 24 months. Plan for the timeline, and let real scarcity do the closing. * Keep relationships warm with simple, consistent systems. One specific, human outreach still opens doors most people never try. * The weekend call test reveals founder quality faster than any deck. Guest: Sam Tidswell-Norrish, Partner at Access Holdings, Chair of OPUS, and founding team member at Motive Partners. Host: Niclas Schlopsna, partner at spectup. About spectup: Capital advisory for companies raising from institutional investors (family office, VC, private equity) and for GPs raising a new fund and need intros to Limited partners This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

  2. Season 2, Episode 2 Trailer

    How Sam Raised Nearly $10 Billion in Private Equity (His Best Tool Is Networking)

    Capital raising in private equity runs on relationships, and few people have built them better than Sam. He helped raise nearly $10 billion across private equity funds, and his most effective deal-making tool is a pub he bought in London. In this clip from Deal Makers (& Fakers), Sam Tidswell-Norrish sat with Niclas Schlopsna, partner at spectup, breaks down the capital raising and networking system behind a $10B career: * How he builds relationships with investors and LPs, sources deals, and turns cold outreach into warm intros? * The pens, the pub, and the LinkedIn message that put one of tech’s most important inventors on his board. Who is Sam Tidswell-Norrish? Sam was Managing Director & Founding Team Member at Motive Partners, runs capital raising and investor relations at Access Holdings, and chairs OPUS, a global community for early-stage founders raising their first rounds. Who this is for? If you’re a founder raising capital, an investor sourcing deals, or anyone trying to understand how private equity fundraising and LP relationships really work, start here. Thanks for reading Deal Makers (& Fakers)! This post is public so feel free to share it. Inside the full episode The full episode covers: * The 7 Ps of raising a fund, private equity fundraising vs startup fundraising * Why there are more PE firms than McDonald’s? * How to build investor relationships before you ever need money? The full episode drops this Friday. Subscribe to get weekly capital raising and private equity fundraising breakdowns from people who’ve actually done it, straight to your inbox. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    How Sam Raised Nearly $10 Billion in Private Equity (His Best Tool Is Networking)
  3. Jun 12

    A $400M Fund's Contrarian Bet Against AI Startups | Denis x spectup

    In this exclusive episode, we reveal why a $400M New York fund is passing on standard software loops to invest heavily in the physical industries building the future. A few days ago, Niclas Schlöpsna sat down with Denis, the visionary lead behind 2BF Global Ventures, a premier New York-based venture capital firm commanding over $400 million in assets under management. Drawing from his fifth consecutive fund and an impressive portfolio featuring market leaders like ServiceTitan and Fubo, Denis shares a contrarian investment thesis that directly opposes standard industry logic. As a former rocket scientist holding dual Master’s Degrees from the prestigious Moscow Institute of Physics and Technology, he has built one of the world's most foundational global communities for SpaceTech founders. What You’ll Learn in This Video Podcast? You will learn how to align your goals with the expectations of an experienced investment fund manager.- The $400M Fund Thesis: Inside the capital allocation strategy of 2BF Global Ventures’ fifth active fund.- 11,000 Pitch Decks Decoded: The core patterns, fatal errors, and traction markers analyzed across 12 years of venture profiling.- The Frontier Tech Paradox: Why a trained rocket scientist focuses on heavy foundational industries over fleeting digital trends.- Building a SpaceTech Community: Deconstructing how specialized global networks help niche tech operators scale efficiently.- The Contrarian Investor Mindset: Overcoming standard analyst groupthink to capture exceptional value in uncrowded, high-barrier markets. About spectup: Capital advisory for companies raising from institutional investors (family office, VC, private equity) and for GPs raising a new fund and need intros to Limited partners Subscribe for weekly startup funding advice and analysis. Tell us in the comments which part of the venture capital strategy process you want us to cover next. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    A $400M Fund's Contrarian Bet Against AI Startups | Denis x spectup
  4. May 29

    From a €15M market operator to a €30M VC – Secrets of a Venture Capitalist

    In this episode of Deal Makers, Niclas Schlopsna sits down with Vlad Sarca, General Partner at Sparking Capital, to unlock the raw, behind-the-scenes mechanics of early-stage venture capital. What actually goes through a venture capitalist's mind when they review your pitch deck? Vlad breaks down the exact framework he uses to evaluate founders, moving past the superficial "AI" buzzwords that often ruin otherwise strong pitches. For founders navigating capital advisory and venture capital, understanding these dynamics is crucial for improving your startup’s quality of life and survival rate in a competitive market. We also dive deep into the Eastern European tech ecosystem, deconstructing the secret price arbitrage giving regional startups a massive edge and how the "EU-Inc" initiative could stop founders from fleeing to Delaware. This perspective is essential for driving regional economic development and building a sustainable legacy in global tech. What You’ll Learn in This Video Podcast? - The 10% Pass Rate: Why the vast majority of pitch decks are immediately rejected during the initial screening process. - The "AI" Trap: Why forcing tech buzzwords into your deck is killing your credibility with experienced investors. - Cap Table Death Traps: The specific equity splits, unengaged academic mentors, and broken ownership structures that make your startup completely uninvestable. - VC Syndicates & Partnerships: How venture capitalists simultaneously compete and collaborate behind the scenes to close high-quality deals. - The Price Arbitrage Advantage: How Eastern European startups leverage lower operational costs to achieve massive scalability with less capital. - Term Sheet Realities: The exact founder behaviours, unrealistic projections, and lack of responsibility that cause VCs to pull out of a deal. Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. About spectup: At spectup, we provide high-stakes capital advisory for founders looking to scale their impact. Capital advisory for companies raising from institutional investors (family office, VC, private equity) and for GPs raising a new fund and need intros to Limited partners Check out www.spectup.com This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    From a €15M market operator to a €30M VC – Secrets of a Venture Capitalist
  5. May 15

    From academic research to raising €4.5M Capital for AI-powered Scent Tech

    The wellness industry is growing rapidly, with unique sensory innovations now leading the way in sleep health. In this episode, Niclas Schlöpsna, Managing Partner at spectup, sits down with Dr. Emanuela Maggioni, CEO of Hynt Labs, to discuss how a sophisticated lab project secured €4.5M in total capital. Thanks for reading Deal Makers (& Fakers)! This post is public so feel free to share it. Emanuela, an expert with 20 years of experience in olfactory science and neuroscience, shares her journey from researching at Sussex and University College London (UCL) to leading a high-growth deep-tech company. We explore how Hynt Labs utilises real-time scent interventions to optimise sleep stages by integrating via APIs with established wearables like: Oura, Samsung Watch, and WHOOP. What You Will Learn? - The €4.5M Funding Strategy: How Hynt Labs combined €3.5M in equity and €1 M (£1M) in research grants. - The Pivot to Sleep Tech: Why moving from general sensory widgets to targeted sleep intervention was the key to commercial success. - Davos & Global Marketing: How demonstrating technology at the World Economic Forum acted as a massive growth multiplier. - Lab to Boardroom: Overcoming the academic mindset to embrace B2B licensing and business clarity. -Deep Tech Landscape: Navigating the differences between European and US investment risks Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. About spectup: Capital advisory for comapnies raising from institutional investors (family office, VC, private equity) and for GPs raising a new fund and need intros to Limited partners Check out: www.spectup.com This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    From academic research to raising €4.5M Capital for AI-powered Scent Tech
  6. Season 1, Episode 10 Trailer

    She raised €4.5M without giving equity.

    In this exclusive trailer for Episode 10 of Deal Makers (& Fakers), Niclas Schlöpsna, Managing Partner at spectup, sits down with Dr. Emanuela Maggioni, the founder of Hynt Labs. Dr. Emanuela Maggioni reveals how she is transforming wearable data from devices like Oura, Samsung Watch, and WHOOP into real-time sensory interventions to improve sleep performance. This perspective highlights the bridge between complex neuroscience and the consumer wellness market, illustrating how economic development in the deep tech sector is set to improve the quality of life for millions. Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. Key takeaways of the session: - The Power of Sensory Science: How Hynt Labs uses scent as a superpower to deconstruct and optimise human rest. - A Multi-Million Euro Strategy: The breakdown of securing €2.9M in equity and €1M in grants to fuel global scaling. - Wearable Integration: How Hint's software solutions leverage the APIs of top trackers to deliver personalised interventions. - Why major global corporations are actively seeking partnerships with Dr. Maggioni's team. Thanks for reading Deal Makers (& Fakers)! This post is public so feel free to share it. About spectup: At spectup, we provide high-stakes capital advisory for founders looking to scale their impact. We believe in building a future where innovation and responsibility go hand-in-hand For more details, visit: www.spectup.com This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

  7. Apr 24

    From Mastercard to Raising $5M from 20VC on a Weekend

    Raising millions at record speed is often portrayed as luck, but for serial founders, it’s a calculated play of leverage, unit economics, and deep-tech infrastructure. In this episode of Deal Makers (& Fakers), Niclas Schlopsna sits down with Kirk to break down the transition from corporate leadership at Mastercard to navigating the Death Valley of fintech startups. Kirk shares his journey of leveraging a $45M exit to bypass the standard fundraising cycle, closing a $5M round in a single weekend. He also shared why he believes your unit economics matter infinitely more than a flashy UI. What you’ll learn in this episode: * The $5M Weekend: How to leverage a previous exit to bypass the standard 6-month fundraising grind. * Fintech Economics: Why today’s investors are pivoting away from “shiny” apps toward deep-tech infrastructure. * Stealth Mode vs. Hype: When (and why) to keep your billion-dollar ideas quiet to protect your competitive advantage. * Corporate to Founder: The raw reality of moving from a C-suite office to the startup trenches. If you’re a founder building in fintech, navigating regulatory compliance, or trying to master the art of the fast raise, this episode reveals the strategic blueprint behind the capital. Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. Who is Kirk Donohoe? Kirk is a serial entrepreneur and former Mastercard executive with a track record of high-stakes exits. He is currently focused on Grand, solving the deep-seated inefficiencies in global financial infrastructure. He previously founded WhenThen (acquired by Mangopay) and held leadership roles at Mastercard. He is a veteran of the fintech space, specializing in global payment infrastructure. About the podcast: Deal Makers (& Fakers) is a spectup podcast where founders and operators reveal what actually works in fundraising, investor outreach, and building companies, plus the fakers moments nobody posts about on LinkedIn. Thanks for reading Deal Makers (& Fakers)! This post is public so feel free to share it. Who should listen? * Fintech founders looking to scale beyond the “app” layer. * Serial entrepreneurs planning their next big exit. * Investors tracking the shift from B2C to B2B infrastructure. Visit spectup.com for more insights on fundraising strategy and startup growth. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    From Mastercard to Raising $5M from 20VC on a Weekend
  8. Apr 10

    He raised $400M for Biotech, an MIT PhD and a secret to the Roche deal.

    🚀 Episode 8 of Deal Makers (& Fakers) - with Armon Sharei, Founder of Portal Bio and SQZ Biotech. Biotech startup IPO success and raising $400M in venture capital is a dream for many founders, but what happens after you go public? In this episode of Deal Makers (& Fakers), Niclas Schlopsna sits down with Armon Sharei, former founder of SQZ Biotech and current founder of Portal Bio, to discuss scaling cell therapy and the reality of the biotech industry. Armon Sharei shares his journey from a PhD at MIT under Robert Langer to closing a massive deal with Roche and leading a publicly traded company. Learn about the "Squeeze" technology, the biotech nuclear winter, and the death spiral that led him to start his second venture, Portal Bio. How did Armon Sharei start his journey? It began at MIT, where he developed a "cell-squeezing" technology that caught the attention of the scientific community and led him to launch: SQZ Biotech with little more than "napkin maths" and a $100,000 initial investment from professors and family. As he transitioned from a PhD student to a full-time CEO, he successfully navigated the venture capital landscape by leveraging the following: * Early academic validation * A prestigious partnership with Roche to secure a $5 million Series A. This momentum eventually snowballed into raising over $400 million, including a massive IPO in 2020, proving that a targeted, platform-focused strategy can bridge the gap between complex deep-tech research and large-scale public market success. What you’ll learn in this episode: - How to raise a Seed Round with no track record.- The secret to closing a partnership with Big Pharma (Roche & Pfizer).- Why the public market might be better than private equity for biotech.- How to identify red flags in venture capital investors. The future of cell therapy and global healthcare innovation. If you’re a founder navigating the complexities of deep tech, big pharma partnerships, or the pressures of the public market, this episode reveals what it takes to build, lose, and rebuild a world-changing company. Thanks for reading Deal Makers (& Fakers)! Subscribe for free to receive new posts and support my work. 👉 Who is Armon Sharei? Armon is the founder of Portal Bio and the former CEO of SQZ Biotech. With a PhD from MIT, his work in cell therapy has been recognised as one of the "10 World Changing Ideas" by Scientific American. He is now focused on making cell therapy more accessible through his latest venture. 👉 About the podcast: Deal Makers (& Fakers) Deal Makers (& Fakers) is a spectup podcast where founders and operators reveal what actually works in fundraising, investor outreach, and building companies, plus the “fakers” moments nobody posts about on LinkedIn. Thanks for reading Deal Makers (& Fakers)! This post is public so feel free to share it. 👉 Who should listen? - Deep tech & biotech founders looking to scale.- Entrepreneurs interested in the transition from scientist to CEO.- Investors wanting to understand the future of cell therapy. 👉 Visit spectup.com for more insights on fundraising strategy and startup growth.🔔 Subscribe for more deep dives with world-class entrepreneurs and investors. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit dealmakersandfakers.substack.com

    He raised $400M for Biotech, an MIT PhD and a secret to the Roche deal.

Trailers

About

Deal Makers (& Fakers) is my podcast where fundraising gets real. No polished success stories. No fake LinkedIn wins. dealmakersandfakers.substack.com